Company Overview

Company name: Veritas Pharma (CNQ: VRT)
Also known as:
Description: Provider of pharmaceutical development services. The company’s pharmaceutical development services include developing innovative medicinal cannabis cultivars for specific disease conditions such as chronic pain, emesis (nausea/vomiting) and epilepsy, enabling patients to get treated for various medical complications.
Year founded: 2014
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Website: www.veritaspharmainc.com
Employees:
City: Vancouver
State: British Columbia
Country: Canada
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 3.00
Business status: Generating Revenue
Ownership: Publicly Held
Exchange: CNQ
Ticker: VRT
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million) -11.28
Enterprise value: 11.19
Earnings before interest, tax, depreciation and amortization (EBITDA): -11.36
Fiscal period: TTM 1Q2019
Financing Status: The company (CNQ: VRT) received CAD 3.043 million of development capital from Marapharm Ventures (CNQ: MDM) and other undisclosed investor on May 21, 2018 through a private placement.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation:
Last known valuation date: